Fredun Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 776.46 million compared to INR 531.2 million a year ago. Revenue was INR 779.56 million compared to INR 542.33 million a year ago. Net income was INR 34.57 million compared to INR 18.72 million a year ago. Basic earnings per share from continuing operations was INR 7.66 compared to INR 4.22 a year ago.
For the nine months, sales was INR 776.46 million compared to INR 1,522.9 million a year ago. Revenue was INR 779.56 million compared to INR 1,542.44 million a year ago. Net income was INR 34.57 million compared to INR 40.4 million a year ago. Basic earnings per share from continuing operations was INR 7.66 compared to INR 10.13 a year ago.